Day One Biopharmaceuticals Inc (DAWN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $10.65
• Market Cap: $1.12B
• EPS: $-1.52
• 52-Week High: $13.20
• 52-Week Low: $5.63

Market Sentiment

Day One Biopharmaceuticals Inc currently has a Bullish sentiment score of 0.35.

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing targeted therapies for genetically defined cancers. The company is distinguished by its robust pipeline of treatments designed to address significant unmet medical needs in oncology, employing precision medicine to enhance patient outcomes. By leveraging innovative scientific approaches that specifically target genetic mutations present in tu...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Day One Biopharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DAWN pay dividends?

Day One Biopharmaceuticals Inc (DAWN) does not currently pay a regular dividend.

What is DAWN's market cap?

Day One Biopharmaceuticals Inc (DAWN) has a market capitalization of $1.12B with a current stock price of $10.65.